Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Herpes simplex Infection

Free Subscription Articles published in Br J Dermatol Retrieve available abstracts of 6 articles: HTML format

Single Articles

February 2023
1. STEELE L, Innes S, Oldham J, Cunningham M, et al
   Safety outcomes for topical corticosteroid use in eczema herpeticum: a single-centre retrospective cohort study.
   Br J Dermatol. 2023;188:295-297.
   PubMed    
   
   
   December 2022
2. GRIFFITHS-ACHA J, Vela-Ganuza M, Sarro-Fuente C, Lopez-Estebaranz JL, et al
   Monkeypox: a new differential diagnosis when addressing genital ulcer disease.
   Br J Dermatol. 2022;187:1050-1052.
   PubMed     Abstract available
   
   
   September 2022
3. SIMPSON EL, Merola JF, Silverberg JI, Reich K, et al
   Safety of Tralokinumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-blind, Placebo-controlled Phase 2 and Phase 3 Trials.
   Br J Dermatol. 2022 Sep 9. doi: 10.1111/bjd.21867.
   PubMed     Abstract available
   
   
   May 2022
4. PONTES FSC, Pereira GG, da Silva Santos PS, Pontes HAR, et al
   Isotretinoin and herpes simplex virus infection.
   Br J Dermatol. 2022 May 11. doi: 10.1111/bjd.21610.
   PubMed    
   
   
   April 2022
5. BIEBER T, Reich K, Paul C, Tsunemi Y, et al
   Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response, Intolerance, or Contraindication to Cyclosporine: Results From a Randomized, Placebo-Control
   Br J Dermatol. 2022 Apr 28. doi: 10.1111/bjd.21630.
   PubMed     Abstract available
   
   
   December 2020
6. XU R, Zhou Y, Cai L, Wang L, et al
   Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19.
   Br J Dermatol. 2020;183:1145-1147.
   PubMed    
   
   

Thank you for your interest in scientific medicine.

AMEDEO Herpes simplex Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: